A humanized anti-CD3 monoclonal antibody, visilizumab, for treatment of severe steroid-refractory ulcerative colitis: Preliminary results of a phase I study
暂无分享,去创建一个
S. Targan | M. Regueiro | S. Hanauer | S. Plevy | W. Sandborn | L. Mayer | B. Salzberg | I. Walters